NEW YORK (GenomeWeb News) – BioNano Genomics said this week that it has elected Albert Luderer to its board of directors. Luderer currently serves as CEO and director of Integrated Diagnostics. He was previously president and CEO of BioTrove, now part of Life Technologies. Previously, he served as CEO of Light Sciences and president and COO of BioMérieux. He has also held senior management positions at Dianon Systems (LabCorp); Boehringer Mannheim (Roche); and Corning.
Diagnostic biomarker developer BG Medicine has signed a consulting agreement with Stéphane Bancel, who became chairman of its board of directors in July, that will pay him a fee of $150,000 per year and a consulting bonus up to $50,000 per year. Bancel formerly was CEO of BioMérieux and he was an executive at Eli Lilly Laboratories.
Li Zhang has been appointed to the scientific advisory board at Saladax Biomedical. Zhang is a professor of medical oncology and deputy director of the Lung Cancer Research Centre of the Sun Yat-sen University and associate director of the National Anti-Cancer Drug Clinical Research Centre at the university. Zhang's studies are focused on development of molecular, prognostic, and therapeutic approaches to improving care for patients with lung, head, and neck cancers, and in studies of cancer-induced anemia.
Molecular Diagnostics company Health Discovery Corporation has named John Hadden to be senior VP of national and international business development. Hadden formerly oversaw new products, sales, alliances, mergers and acquisitions at Quest Diagnostics. Before he was at Quest Hadden was senior VP of business development at American Medical Laboratories, senior VP at LabOne (which was acquired by Quest), and he was associate VP for LabCorp.
OraSure Technologies has appointed Gerald Ostrov to its board of directors. Ostrov most recently served as chairman and CEO of Bausch & Lomb from 2008 to 2010. Prior to that he spent the majority of his career with Johnson & Johnson, where he held the position of company group chairman responsible for the worldwide vision care businesses, until he retired in 2006.
The Personalized Medicine Coalition has awarded Leroy Hood, president and co-founder of the Institute for Systems Biology, its 2011 Leadership in Personalized Medicine Award. The PMC recognized Hood for his "pioneering vision to transform medicine from reactive to predictive, preventive, personalized and participatory (P4 medicine)." Hood and his colleagues helped develop the DNA and sequencers that were instrumental in mapping the human genome.
Lisa Barclay has been appointed the Food and Drug Law Institute's chief of staff for the FDA. She is a partner at the law firm of Zuckerman Spaeder in Washington, DC, where she practices in food and drug law, among other areas. She also worked in the Office of the Commissioner at the Food and Drug Administration between 1995 and 2001.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.